NASDAQ:PLXS - Plexus Stock Price, Price Target & More

Plexus trades on the NASDAQ under the ticker symbol "PLXS."

Plexus announced that its board has approved a share repurchase program on Wednesday, February 21st 2018, which authorizes the company to buyback $200,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to buy shares of its stock through open market purchases. Stock buyback programs are generally an indication that the company's management believes its stock is undervalued.

Plexus Corp. (NASDAQ:PLXS) posted its quarterly earnings data on Wednesday, April, 25th. The technology company reported $0.74 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.74. The technology company earned $699 million during the quarter, compared to analysts' expectations of $691.05 million. Plexus had a negative net margin of 1.19% and a positive return on equity of 10.96%. The firm's revenue for the quarter was up 15.7% on a year-over-year basis. During the same quarter last year, the business earned $0.84 EPS. View Plexus' Earnings History.

Plexus is scheduled to release their next quarterly earnings announcement on Wednesday, July, 18th 2018. View Earnings Estimates for Plexus.

Plexus updated its third quarter earnings guidance on Wednesday, April, 25th. The company provided earnings per share (EPS) guidance of $0.76-0.86 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.87. The company issued revenue guidance of $700-740 million, compared to the consensus revenue estimate of $710.67 million.

5 brokerages have issued 12-month price targets for Plexus' stock. Their forecasts range from $54.00 to $70.00. On average, they anticipate Plexus' stock price to reach $60.75 in the next year. View Analyst Ratings for Plexus.

Plexus saw a increase in short interest in May. As of May 15th, there was short interest totalling 1,078,003 shares, an increase of 51.7% from the April 30th total of 710,382 shares. Based on an average daily volume of 200,317 shares, the days-to-cover ratio is currently 5.4 days. Approximately 3.3% of the company's stock are sold short.

Some companies that are related to Plexus include Flex (FLEX), Jabil (JBL), Sanmina (SANM), TTM Technologies (TTMI), Celestica (CLS), Benchmark Electronics (BHE), CTS (CTS), Kimball Electronics (KE), Park Electrochemical (PKE), Sparton (SPA), SMTC (SMTX), IEC Electronics (IEC), NANO DIMENSION/S (NNDM), SigmaTron International (SGMA) and Eltek (ELTK).

News stories about PLXS stock have trended somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies negative and positive media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Plexus earned a coverage optimism score of 0.10 on Accern's scale. They also gave news coverage about the technology company an impact score of 45.85 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Plexus' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (13.17%), Disciplined Growth Investors Inc. MN (8.89%), Dimensional Fund Advisors LP (8.50%), Barrow Hanley Mewhinney & Strauss LLC (4.37%), Franklin Resources Inc. (3.70%) and Northern Trust Corp (3.11%). Company insiders that own Plexus stock include Angelo Michael Ninivaggi Jr, David J Drury, Dean A Foate, Michael V Schrock, Oliver K Mihm, Patrick John Jermain, Peter Kelly, Ralf R Boer, Ronnie Darroch, Stephen P Cortinovis, Steven J Frisch, Todd P Kelsey and Yong Jin Lim. View Institutional Ownership Trends for Plexus.

PLXS stock was sold by a variety of institutional investors in the last quarter, including American Century Companies Inc., Disciplined Growth Investors Inc. MN, Massachusetts Financial Services Co. MA, JPMorgan Chase & Co., Vaughan Nelson Investment Management L.P., Citigroup Inc., Barrow Hanley Mewhinney & Strauss LLC and Royal Bank of Canada. Company insiders that have sold Plexus company stock in the last year include Angelo Michael Ninivaggi Jr, David J Drury, Dean A Foate, Michael V Schrock, Oliver K Mihm, Patrick John Jermain, Ralf R Boer, Ronnie Darroch, Stephen P Cortinovis, Steven J Frisch, Todd P Kelsey and Yong Jin Lim. View Insider Buying and Selling for Plexus.

PLXS stock was bought by a variety of institutional investors in the last quarter, including Thrivent Financial for Lutherans, Cooke & Bieler LP, Silvercrest Asset Management Group LLC, Scout Investments Inc., Carillon Tower Advisers Inc., BlackRock Inc., Dean Investment Associates LLC and Franklin Resources Inc.. View Insider Buying and Selling for Plexus.

Shares of PLXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PLXS stock can currently be purchased for approximately $61.00.

Plexus has a market capitalization of $2.02 billion and generates $2.53 billion in revenue each year. The technology company earns $112.06 million in net income (profit) each year or $3.24 on an earnings per share basis. Plexus employs 16,000 workers across the globe.

Plexus' mailing address is One Plexus Way, Neenah WI, 54957. The technology company can be reached via phone at 920-969-6000 or via email at [email protected]